Singular Genomics Systems Inc (OMIC)
22.77
+0.02
(+0.09%)
USD |
NASDAQ |
Nov 15, 09:46
Singular Genomics Systems Free Cash Flow (Quarterly): -18.04M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -18.04M |
| March 31, 2024 | -23.73M |
| December 31, 2023 | -19.29M |
| September 30, 2023 | -16.92M |
| June 30, 2023 | -20.30M |
| March 31, 2023 | -18.10M |
| December 31, 2022 | -21.74M |
| September 30, 2022 | -22.91M |
| June 30, 2022 | -27.69M |
| Date | Value |
|---|---|
| March 31, 2022 | -20.78M |
| December 31, 2021 | -17.47M |
| September 30, 2021 | -12.60M |
| June 30, 2021 | -16.81M |
| March 31, 2021 | -9.692M |
| December 31, 2020 | -7.223M |
| September 30, 2020 | -7.389M |
| June 30, 2020 | -6.671M |
| March 31, 2020 | -4.97M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-27.69M
Minimum
Jun 2022
-4.97M
Maximum
Mar 2020
-16.24M
Average
-17.75M
Median
Free Cash Flow (Quarterly) Benchmarks
| Bruker Corp | 5.80M |
| Azenta Inc | -4.802M |
| Harvard Bioscience Inc | -1.953M |
| Bionano Genomics Inc | -21.06M |
| Akoya Biosciences Inc | -11.21M |